10 BÜCHER, DIE MIT «KRUPADA» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
krupada in der folgenden bibliographischen Auswahl. Bücher, die mit
krupada im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
1
Human Growth Hormone: Research and Clinical Practice - Strona 65
Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab 1994;79:943–949 ...
Roy G. Smith, Michael O. Thorner,
2000
2
Growth Hormone Secretagogues: Basic Findings and Clinical ...
Gertz, B.J., Barret, J.S., Eisenhaendler, R., Krupa, D.A., Wittreich, J.M., Seibold, J.R. and Schneider, S.H. (1993) Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. JCE&M 77 ...
E. Ghigo, M. Boghen, F.F. Casanueva,
1999
3
Insecticides with Novel Modes of Action: Mechanisms and ...
ACS Symp Ser no 255. American Chemical Society, Washington, DC, pp 5–20 Campos F, Dybas RA, Krupa DA (1995) Susceptibility of twospotted spider mite, Tetranychus urticae (Acari: Tetranychidae) populations in California to abamectin.
Isaac Ishaaya, Danny Degheele,
2013
4
Biorational Control of Arthropod Pests: Application and ... - Strona 386
J Econ Entomol 90: 1 125-1 130 Campos F, Dybas RD, Krupa DA (1995) Susceptibility of twospotted spider mite (Acari: Tetranychidae) populations in California to abamectin. J Econ Entomol 88: 225-231 Campos F, Krupa DA, Dubas RA ...
Isaac Ishaaya, A. Rami Horowitz,
2009
5
Growth Hormone in Adults: Physiological and Clinical Aspects
Endocrinology 135: 1100–1108 Hickey, G., Jacks, T., Schleim, K., Frazier, E., Chen, H.Y., Krupa, D.A., Feeny, W.P., Nargund, R.P., Patchett, A.A., Smith, R.G. (1997). Repeat administration of growth hormone secretagogue MK-0677 increases ...
Anders Juul, Jens O. L. Jorgensen,
2000
6
Insect Pharmacology: Channels, Receptors, Toxins and Enzymes
5–20. Campbell, W.C., Fisher, M.H., Stapley, E.O., AlbersSchonberg, T., Jacob, T.A., 1983. Ivermectin: a potent new antiparasitic agent. Science 221, 923–928. Campos, F.C., Dybas, R.A., Krupa, D.A., 1995. Susceptibility of twospotted spider ...
Lawrence I. Gilbert, Sarjeet S. Gill,
2010
7
Food for the Ageing Population - Strona 66
Drugs Aging 9, 221±5. CHAPMAN IM (2004): Endocrinology of anorexia of aging. Best Pract & Res 18 (3), 437± 52. CHAPMAN JM, BACH MA, VAN CAUTER E, FARMER M, KRUPA DA, TAYLOR AM, SCHILLING LM, COLE KY, SKYLES EH, ...
M M Raats, Lisette De Groot, Dieneke van Asselt,
2008
8
Rethinking Corporate Governance: From Shareholder Value to ...
... to the supervisory board constitutes a drawback (mankament) from the point of view of the owners of the company as it restricts the freedom of management. See also R. Krupa-Da ̨browska, Przedsie ̨biorcy nieche ̨tni spo ́łkom ...
Roger Blanpain, William Bromwich, Olga Rymkevich,
2011
9
From Acute to Chronic Back Pain: Risk Factors, Mechanisms, ...
Katz, N.P., Iu, W.D., Krupa, D.A., et al. (2003). Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4—week, randomized, placebo—controlled, parallel— group, double—blind trials. Spine, 28, 851-59. Keefe ...
Monika I. Hasenbring, Adina C. Rusu, Dennis C. Turk,
2012
10
Evidence-Based Management of Low Back Pain - Strona 153
Ju WD, Krupa DA, Walters DJ, et al. A placebo-controlled trial of rofecoxib in the treatment of chronic low back pain. Pain Med 2001;2:242-243. Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of ...
Simon Dagenais, Scott Haldeman,
2011